Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
01:11:17 min
CLEAR ALL
This weeks video looks at the effects of MDMA/ecstasy and ketamine as a treatment option for ptsd. The biological mechanisms involved in these drugs for ptsd as well as depression/anxiety are mentioned, as well as the therapeutic benefits and research in the area.
1
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
Phil Wolfson, MD, and Julane Andries, MFT MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness
We are excited to bring you the executive director of MAPS- As we dive into the world of psychedelics and their uses in the world of medicine.
Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
2
Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.
REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.
MDMA, better known as ecstasy, molly, or one of a number of other street names, is a stimulant drug with unique prosocial effects. In this video, I discuss the current understanding of how MDMA acts on the brain to produce its effects.
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.